Nitric oxide: pros and cons in tumor progression

References

• Lala, P.K. Significance of nitric oxide in carcinogeneses, tumor progression and cancer therapy. Cancer. Metastasis. Rev. 1998, 17, 1–6.
   PubMedGoogle Scholar
• Stuehr, D.J., Nathan, C.F. Nitric oxide. A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J. Exp. Med. 1989, 169, 1543–1555.
   PubMed Web of Science ®Google Scholar
• Kwon, N.S., Stuehr, D.J., Nathan, C.F. Inhibition of tumor cell ribonucleotide reductase by macrophage-derived nitric oxide. J. Exp. Med. 1991, 174, 761–767.
   PubMed Web of Science ®Google Scholar
• Felley-Bosco E. (1998). Role of nitric oxide in genotoxicity: implication for carcinogenesis. Cancer Metastasis Rev, 17, 25–37.
   PubMed Web of Science ®Google Scholar
• Xie, K., Huang, S., Dong, Z., Juang, S.H., Gutman, M., Xie, Q.W., Nathan, C., Fidler, I.J. Transfection with the inducible nitric oxide synthase gene suppresses tumorigenicity and abrogates metastasis by K-1735 murine melanoma cells. J. Exp. Med. 1995, 181, 1333–1343.
   PubMed Web of Science ®Google Scholar
• Thomsen, L.L., Lawton, F.G., Knowles, R.G., Beesley, J.E., Riveros-Moreno, V., Moncada, S. Nitric oxide synthase activity in human gynecological cancer. Cancer Res. 1994, 54, 1352–1354.
   PubMed Web of Science ®Google Scholar
• Knowles, R.G., Moncada, S. Nitric oxide synthases in mammals. Biochem. J. 1994, 298 (Pt 2), 249–258.
   PubMedGoogle Scholar
• Morris, S.M. Jr, Billiar, T.R. New insights into the regulation of inducible nitric oxide synthesis. Am. J. Physiol. 1994, 266, E829–E839.
   PubMed Web of Science ®Google Scholar
• Sappayatosok, K., Maneerat, Y., Swasdison, S., Viriyavejakul, P., Dhanuthai, K., Zwang, J., Chaisri, U. Expression of pro-inflammatory protein, iNOS, VEGF and COX-2 in oral squamous cell carcinoma (OSCC), relationship with angiogenesis and their clinico-pathological correlation. Med. Oral Patol. Oral Cir. Bucal 2009, 14, E319–E324.
   PubMed Web of Science ®Google Scholar
• Xie, K., Dong, Z., Fidler, I.J. Activation of nitric oxide synthase gene for inhibition of cancer metastasis. J. Leukoc. Biol. 1996, 59, 797–803.
   PubMed Web of Science ®Google Scholar
• Kian–Huat Lim, Ancrile, B.B., Kashatus, DF, Counter CM. Tumor maintenance is mediated by eNOS. Nature. 2008, 452, 646–649.
   PubMedGoogle Scholar
• Jadeski, L.C., Chakraborty, C., Lala, P.K. Nitric oxide-mediated promotion of mammary tumour cell migration requires sequential activation of nitric oxide synthase, guanylate cyclase and mitogen-activated protein kinase. Int. J. Cancer. 2003, 106, 496–504.
   PubMed Web of Science ®Google Scholar
• Papapetropoulos. A., García-Cardeña, G., Madri, J.A., Sessa, W.C. Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. J. Clin. Invest. 1997, 100, 3131–3139.
   PubMed Web of Science ®Google Scholar
• Fukumura, D., Jain, R.K. Role of nitric oxide in angiogenesis and microcirculation in tumors. Cancer. Metastasis. Rev. 1998, 17, 77–89.
   PubMed Web of Science ®Google Scholar
• Ridnour, L.A., Douglas, D.D., Donzelli, S., Espey, M.G., Isenberg, J.S., Tocchetti, C.G., King, S.B., Lazzarino, G., Miranda, K.M., Roberts, D.D., Feelisch, M., Wink, D.A. The biophasic nature of nitric oxide responses in tumor biology. Antioxid. Redox. Signal. 2006, 8, 1329–1337.
   PubMed Web of Science ®Google Scholar
• Fukumura, D., Yuan, F., Endo, M., Jain, R.K. Role of nitric oxide in tumor microcirculation. Blood flow, vascular permeability, and leukocyte-endothelial interactions. Am. J. Pathol. 1997, 150, 713–725.
   PubMed Web of Science ®Google Scholar
• Tatemichi M, Ogura T, Esumi H. Impact of inducible nitric oxide synthase gene on tumor progression. Eur. J. Cancer. Prev. 2009, 18, 1–8.
   PubMedGoogle Scholar
• Folkman, J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med. 1995, 1, 27–31.
   PubMed Web of Science ®Google Scholar
• Fukumura, D., Kashiwagi, S., Jain, R.K. The role of nitric oxide in tumor progression. Nature. Rev. Cancer. 2006, 6, 521–534.
   PubMed Web of Science ®Google Scholar
• Sagar, S.M., Yance, D., Wong, R.K. Natural health products that inhibit angiogenesis: a potential sources for investigation new agent to treat cancer-part-1. Curr. Oncol. 2006, 13, 99–107.
   PubMedGoogle Scholar
• Ziche, M., Morbidelli, L., Masini, E., Amerini, S., Granger, H.J., Maggi, C.A., Geppetti, P., Ledda, F. Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. J. Clin. Invest. 1994, 94, 2036–2044.
   PubMed Web of Science ®Google Scholar
• Gallo, O., Masini, E., Morbidelli, L., Franchi, A., Fini-Storchi, I., Vergari, W.A., Ziche, M. Role of nitric oxide in angiogenesis and tumor progression in head and neck cancer. J. Natl. Cancer. Inst. 1998, 90, 587–596.
   PubMed Web of Science ®Google Scholar
• Ziche, M. Role of nitric oxide in the angiogenesis of avascular tissue. Osteoarthr. Cartil. 1999, 7, 403–405.
   PubMedGoogle Scholar
• Jenkins, D.C., Charles, I.G., Thomsen, L.L., Moss, D.W., Holmes, L.S., Baylis, S.A., Rhodes, P., Westmore, K., Emson, P.C., Moncada, S. Roles of nitric oxide in tumor growth. Proc. Natl. Acad. Sci. U.S.A. 1995, 92, 4392–4396.
   PubMed Web of Science ®Google Scholar
• al-Sarireh, B., Eremin, O. Tumour-associated macrophages (TAMS): disordered function, immune suppression and progressive tumour growth. J. R. Coll. Surg. Edinb. 2000, 45, 1–16.
   PubMedGoogle Scholar
• Hibbs, J.B. Jr, Taintor, R.R., Vavrin, Z., Rachlin, E.M., Nitric oxide: a cytotoxic activated macrophages effector molecule. Biochem. Biophys. Res. Commun. 1989, 158, 624.
   Google Scholar
• Albena JE, Mills CD, Caldwell MD. (1990). Alteration in macrophage physiology associated with the metabolism of L-arginine trough the oxidative L-arginine deiminase pathway. In: Moncada S. Higgs EA, eds, Nitric Oxide from L-Arginine. A Bioregulatory System ( pp. 189–223). Amesterdam: Elsevier Science Publication B.V.
   Google Scholar
• Gardner, T.E., Naama, H., Daly, J.M. Peritoneal and splenic macrophage functions in the tumor-bearing host. J. Surg. Res. 1995, 59, 305–310.
   PubMed Web of Science ®Google Scholar
• Dinapoli, M.R., Calderon, C.L., Lopez, D.M. The altered tumoricidal capacity of macrophages isolated from tumor-bearing mice is related to reduce expression of the inducible nitric oxide synthase gene. J. Exp. Med. 1996, 183, 1323–1329.
   PubMed Web of Science ®Google Scholar
• Daniela, M., Chiora, M., Alessandro, F., Francesca, B. Arginine metabolism in tumor associated macrophages in cutaneous malignant melanoma; evidence from human and experimental tumor. Human. Pathol. 2007, 38, 1516–1525.
   PubMedGoogle Scholar
• Ohshima, H., Bartsch, H. Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis. Mutat. Res. 1994, 305, 253–264.
   PubMed Web of Science ®Google Scholar
• Kilbourn, R.G., Belloni, P. Endothelial cell production of nitrogen oxides in response to interferon gamma in combination with tumor necrosis factor, interleukin-1, or endotoxin. J. Natl. Cancer Inst. 1990, 82, 772–776.
   PubMed Web of Science ®Google Scholar
• Thiemermann, C., Vane, J. Inhibition of nitric oxide synthesis reduces the hypotension induced by bacterial lipopolysaccharides in the rat in vivo. Eur. J. Pharmacol. 1990, 182, 591–595.
   PubMed Web of Science ®Google Scholar
• Brouet, I., Ohshima, H. Curcumin, an anti-tumour promoter and anti-inflammatory agent, inhibits induction of nitric oxide synthase in activated macrophages. Biochem. Biophys. Res. Commun. 1995, 206, 533–540.
   PubMed Web of Science ®Google Scholar
• Rao, C.V., Indranie, C., Simi, B., Manning, P.T., Connor, J.R., Reddy, B.S. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor. Cancer Res. 2002, 62, 165–170.
   PubMed Web of Science ®Google Scholar
• Ahn, H., Kim, J.Y., Lee, H.J., Kim, Y.K., Ryu, J.H. Inhibitors of inducible nitric oxide synthase expression from Artemisia iwayomogi. Arch. Pharm. Res. 2003, 26, 301–305.
   PubMedGoogle Scholar
• Zhao, F., Xu, H., He, E.Q., Jiang, Y.T., Liu, K. Inhibitory effects of sesquiterpenes from Saussurea lappa on the overproduction of nitric oxide and TNF-alpha release in LPS-activated macrophages. J. Asian Nat. Prod. Res. 2008, 10, 1045–1053.
   PubMed Web of Science ®Google Scholar
• Ryu, J.H., Jeong, Y.S., Sohn, D.H. A new bisabolene epoxide from Tussilago farfara, and inhibition of nitric oxide synthesis in LPS-activated macrophages. J. Nat. Prod. 1999, 62, 1437–1438.
   PubMed Web of Science ®Google Scholar
• Bor, J.Y., Chen, H.Y., Yen, G.C. Evaluation of antioxidant activity and inhibitory effect on nitric oxide production of some common vegetables. J. Agric. Food Chem. 2006, 54, 1680–1686.
   PubMed Web of Science ®Google Scholar
• Sheeja, K., Guruvayoorappan, C., Kuttan, G. Antiangiogenic activity of Andrographis paniculata extract and andrographolide. Int. Immunopharmacol. 2007, 7, 211–221.
   PubMed Web of Science ®Google Scholar
• Guruvayoorappan, C., Kuttan, G. Methanol extract of Biophytum sensitivum alters the cytokine profile and inhibits iNOS and COX-2 expression in LPS/Con A stimulated macrophages. Drug. Chem. Toxicol. 2008, 31, 175–188.
   PubMed Web of Science ®Google Scholar
• Guruvayoorappan, C. Kuttan, G. Amentoflavone stimulates apoptosis in B16F-10 melanoma cells by regulating bcl-2, p53 as well as caspase-3 genes and regulates the nitric oxide as well as proinflammatory cytokine production in B16F-10 melanoma cells, tumor associated macrophages and peritoneal macrophages. J. Exp. Ther. Oncol. 2008, 7, 207–218.
   PubMedGoogle Scholar
• Guruvayoorappan, C., Kuttan, G. Apoptotic effect of Biophytum sensitivum on B16F-10 cells and its regulatory effects on nitric oxide and cytokine production on tumor-associated macrophages. Integr. Cancer. Ther. 2007, 6, 373–380.
   PubMedGoogle Scholar
• Guruvayoorappan, C., Kuttan, G. Rutin inhibits nitric oxide and tumor necrosis factor-alpha production in lipopolysaccharide and concanavalin-a stimulated macrophages. Drug. Metab. Drug. Interact. 2007, 22, 263–278.
   PubMedGoogle Scholar
• Jagetia, G.C., Baliga, M.S. The evaluation of nitric oxide scavenging activity of certain Indian medicinal plants in vitro; a preliminary study. J. Med. Food. 2004, 7, 343–348.
   PubMed Web of Science ®Google Scholar
• Basu, S. Comparison of IOL power calculations by the IOLMaster vs theoretical calculations. Eye. (Lond). 2006, 20, 90–97.
   PubMedGoogle Scholar
• Kumari, A., Kakkar, P. Screening of antioxidant potential of selected barks of Indian medicinal plants by multiple in vitro assays. Biomed. Environ. Sci. 2008, 21, 24–29.
   PubMedGoogle Scholar
• Singh, N., Singh, S.M., Shrivastava, P. Immunomodulatory and antitumor actions of medicinal plant Tinospora cordifolia are mediated through activation of tumor-associated macrophages. Immunopharmacol. Immunotoxicol. 2004, 26, 145–162.
   PubMed Web of Science ®Google Scholar
• Pandey, R., Maurya, R., Singh, G., Sathiamoorthy, B., Naik, S. Immunosuppressive properties of flavonoids isolated from Boerhaavia diffusa Linn. Int. Immunopharmacol. 2005, 5, 541–553.
   PubMed Web of Science ®Google Scholar
• Hong, C.H., Hur, S.K., Oh, O.J., Kim, S.S., Nam, K.A., Lee, S.K. Evaluation of natural products on inhibition of inducible cyclooxygenase (COX-2) and nitric oxide synthase (iNOS) in cultured mouse macrophage cells. J. Ethnopharmacol. 2002, 83, 153–159.
   PubMed Web of Science ®Google Scholar
• Cheung, F., Slow, Y.L., Chen, W.Z. Inhibitary effect of Ginko biloba extract on the expression of inducible nitric oxide synthase in endothelial cells. Biochem Pharmacol. 1999, 15, 1665–1673.
   Google Scholar
• Achike, F.I., Kwan, C.Y. Nitric oxide, human diseases and the herbal products that affect the nitric oxide signalling pathway. Clin. Exp. Pharmacol. Physiol. 2003, 30, 605–615.
   PubMed Web of Science ®Google Scholar